Meet neffy: Health Canada approves epinephrine nasal spray for anaphylaxis
TORONTO — Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy.
ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment could be on the market as soon as this summer.
The drug was approved for adults and pediatric patients who weigh at least 30 kilograms, which is roughly 66 pounds. A one-milligram dose has been approved in the United States for kids between 15 and 30 kilograms, but not in Canada.
As it stands, epinephrine auto-injectors — a single-use pre-filled device known by the brand name EpiPen — are the only emergency treatment option available for allergic reactions.

